2014年博士毕业于苏黎世瑞士联邦理工学院 (Swiss Federal Institute of Technology Zürich , ETH Zürich)药学院药剂系。2014年11月份进入哈佛大学医学院Joslin Diabetes Center 免疫系从事博士后研究。2018年12月份加入苏州大学药学院药剂系任特聘教授。主要从事癌症治疗和1型糖尿病治疗领域的药物新剂型的研究。
研究领域
药物新剂型在癌症免疫治疗中的应用药物新剂型在1型糖尿病免疫治疗领域的应用
近期论文
1)Mi Liu, Jean-Christophe Leroux, Marc Andre Gauthier, Conformation–function relationships for the comb-shaped polymer pOEGMA, Progress in Polymer Science, 2015, 48, 111–121 (IF =26.932).2)Mi Liu,Pål Johansen, Jean-Christophe Leroux, and Marc Andre Gauthier, Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo, Nature Communications, 2014, 05, 5526 (IF=12.12).3)Mi Liu, Pasquale Tirino, Milos Radivojevic, Daniel J. Phillips, Matthew I. Gibson, Jean-Christophe Leroux, Marc Andre Gauthier, Molecular sieving on the surface of a protein provides protection without loss of activity. Advanced Functional Materials, 2013, 23, 2007–2015 （IF =12.12）4)Mi Liu,Jianing Fu, Jing Li , Lihui Wang, Qiang Tan, Xiaoyuan Ren，Zuofu Peng, Huihui Zeng, Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method, International Journal of Pharmaceutics, 2010, 391, 292–304 （IF =3.65）
